| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/27/2008 | WO2008002655A3 Crystalline forms of atorvastatin |
| 03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 03/27/2008 | WO2007135530A3 Pharmaceutically & veterinarily suitable salt |
| 03/27/2008 | WO2007115943A3 Process for the preparation of an n-alkyl lactam with improved colour quality |
| 03/27/2008 | WO2007114921A3 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same |
| 03/27/2008 | WO2007084314A3 MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 03/27/2008 | US20080076820 Improving the activities of daily living in a post-stroke patient by administering nefiracetam or its salts initiated within 12 months of stroke; nefiracetam possesses neurotrophic activity |
| 03/27/2008 | US20080076819 Treating non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome; 6-[(1-cycloheptyl-4,4-dimethyl-5-oxopyrrolidin-3-yl)methoxy]nicotinonitrile for example |
| 03/27/2008 | US20080076818 Novel processes for the preparation of dpp iv inhibitors |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076816 Non-Covalent Complexes Comprising Carbon Nanotubes |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076770 -[4-(4,5-dichloro-1H-imidazol-1-yl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; useful for treating hypertensive, cardiovascular, inflammatory, and diabetes related diseases |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/27/2008 | US20080076044 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production |
| 03/27/2008 | US20080075961 condensation of appropriate anhydrides with appropriate diamines to give amine terminated compounds, then condensed with excess maleic anhydride to yield imide-extended maleimide compounds |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903033A1 Coniosetine, process for preparation and use as pharmaceutical |
| 03/26/2008 | EP1903021A1 Process for production of fluorocompounds |
| 03/26/2008 | EP1902313A1 Trityl derivatives for enhancing mass spectrometry |
| 03/26/2008 | EP1902022A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 03/26/2008 | EP1592719B1 Conjugation reactions |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/26/2008 | CN101151244A Histamine H3 receptor agents, preparation and therapeutic uses |
| 03/26/2008 | CN101151232A Process for production of fluorocompounds |
| 03/26/2008 | CN101148468A High efficiency technique for extracting bilirubin and bile acid by using animal bile as raw material |
| 03/26/2008 | CN100376551C Semicarbazone synthesis method |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348427 Substituted with an amido heterocylic groups; infection by Gram-positive bacteria. |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348356 enzyme inhibitor for preventing the formation of insoluble Amyloid beta and arresting the production of Amyloid beta; prevention or treatment of such diseases in which the enzyme is involved; compound including a N-alkyl cycloalkyl group |
| 03/25/2008 | US7348347 Serotonin reuptake inhibitors; for depression and pain; 2-cyclohexyl-N-{4-[4-(2-dimethylaminoethyl)piperazin-1-carbonyl]-4,5,6,7-tetrahydrobenzthiazol-2-yl)-acetamide |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348330 1-azabicyclo [2,2,2] octan-3-one derivatives |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348290 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same |
| 03/25/2008 | CA2315835C New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008031212A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/20/2008 | WO2008031184A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/20/2008 | WO2007147163A3 Compositions comprising carotenoid analogs or derivatives and methods for synthesis |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007136921A3 Small molecule apoptosis promoters |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | US20080071083 Methods for minimizing thioamide impurities |
| 03/20/2008 | US20080070973 succinate and naphthalenedisulfonate salts and solvates of 2-(Methyloxy)-N-[2-methyl-1-phenyl-2-(1-pyrrolidinyl)propyl]-4,6-bis(trifluoromethyl)benzamide; crystalline; block the glycine site of the NMDA receptors; schizophrenia, dementia, attention deficit disorder; ease of isolation in large scale |
| 03/20/2008 | US20080070969 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/20/2008 | US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue |
| 03/20/2008 | US20080070953 Inhibitors of interleukin-1 beta converting enzyme |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663375A1 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 03/19/2008 | EP1900726A1 Heterocyclic thioesters |
| 03/19/2008 | EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 03/19/2008 | EP1899298A2 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 03/19/2008 | EP1899297A1 Zofenopril calcium in polymorph form c |
| 03/19/2008 | EP1899296A1 Histamine-3 receptor antagonists |
| 03/19/2008 | EP1899295A2 Prostaglandin derivatives |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | EP1898940A1 Inhibitors of the alpha2beta 1/gpia-iia integrin |
| 03/19/2008 | CN101146777A Carboxanilides as microbiocides |
| 03/19/2008 | CN101146769A Azolylacylguanidines as beta-secretase inhibitors |
| 03/19/2008 | CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 03/19/2008 | CN101143862A Ionic compound containing chiral amine-thiourea (urea) and its preparation method and application |
| 03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
| 03/18/2008 | US7345179 Reacting 2-hydroxymethyl-n-protected-4-substituted pyrrolidine with arylsulfonyl chloride or an optionally substituted alkylsulfonyl chloride in the presence of a base; reacting with p-hydroxybenzenecarboxylic acid derivative (ethyl 4-(N-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinylmethoxy)benzoate) |
| 03/18/2008 | US7345091 Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/18/2008 | US7345087 Aminocyclohexyl ether compounds and uses thereof |
| 03/18/2008 | US7345086 Uses of ion channel modulating compounds |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | CA2256379C Substance mixtures comprising vinyl-containing compounds and stabilizers |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008028662A1 N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus |
| 03/13/2008 | WO2007147445A3 Keratin-binding effector molecules, and method for the production thereof |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 03/13/2008 | WO2006106372A8 New crystalline atorvastatin hemicalcium salt polymorph form |
| 03/13/2008 | US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 03/13/2008 | US20080064738 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080064737 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080064736 Safe for plant and seed application |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1896411A2 Process for preparing renin inhibitors |
| 03/12/2008 | EP1896036A1 Anti-inflammatory agents |
| 03/12/2008 | EP1896012A2 Anti-inflammatory agents |
| 03/12/2008 | CN101142182A Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors |
| 03/12/2008 | CN101142181A Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives |
| 03/12/2008 | CN101142180A Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 03/12/2008 | CN101141959A 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/12/2008 | CN101139422A Method for synthesizing halogen substituent maleimide heat-proof flame-proof resin emulsion |